Lezi Wang

Lezi Wang

Auto-generated profile, based on publicly available information

Lezi Wang

Digital China Health Technologies Corporation Limited, Beijing, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in JMIR Medical Informatics
Verified
Journal Article
Open access
MGMengchun Gong
Mengchun Gong
SWShuang Wang
Shuang Wang
LWLezi Wang
Lezi Wang
CLChao Liu
Chao Liu
NBNan Bi
Nan Bi
ZHZhouguang Hui
Zhouguang Hui
Background: Patient privacy is a ubiquitous problem around the world. Many existing studies have demonstrated the potential privacy risks associated with sharing of biomedical data. Owing to the increasing need for data sharing and analysis, health care data privacy is drawing more attention. However, to better protect biomedical data privacy, it is essential to assess the privacy risk in the first place. Objective: In China, there is no clear regulation for health systems to deidentify data. It is also not known whether a mechanism such as the Health Insurance Portability and Accountability Act (HIPAA) safe harbor policy will achieve sufficient protection. This study aimed to conduct a pilot study using patient data from Chinese hospitals to understand and quantify the privacy risks of Chinese patients. Methods: We used g-distinct analysis to evaluate the reidentification risks with regard to the HIPAA safe harbor approach when applied to Chinese patients’ data. More specifically, we estimated the risks based on the HIPAA safe harbor and limited dataset policies by assuming an attacker has background knowledge of the patient from the public domain. Results: The experiments were conducted on 0.83 million patients (with data field of date of birth, gender, and surrogate ZIP codes generated based on home address) across 33 provincial-level administrative divisions in China. Under the Limited Dataset policy, 19.58% (163,262/833,235) of the population could be uniquely identifiable under the g-distinct metric (ie, 1-distinct). In contrast, the Safe Harbor policy is able to significantly reduce privacy risk, where only 0.072% (601/833,235) of individuals are uniquely identifiable, and the majority of the population is 3000 indistinguishable (ie the population is expected to share common attributes with 3000 or less people). Conclusions: Through the experiments based on real-world patient data, this work illustrates that the results of g-distinct analysis about Chinese patient privacy risk are similar to those from a previous US study, in which data from different organizations/regions might be vulnerable to different reidentification risks under different policies. This work provides reference to Chinese health care entities for estimating patients’ privacy risk during data sharing, which laid the foundation of privacy risk study about Chinese patients’ data in the future.

1 May 2013
Verified
Conference Paper
Closed access
CHChong Huang
Chong Huang
YDYuan Dong
Yuan Dong
HBHongliang Bai
Hongliang Bai
LWLezi Wang
Lezi Wang
NZNan Zhao
Nan Zhao
Jian ZhaoJian Zhao
Jian Zhao
The state of the art in query expansion is mainly based on the spatial information. These methods achieve high performance, however, suffer from huge computation and memory. The objective of this paper is to perform visual reranking in near-real time regardless of the spatial information. We explore a graph-based method proposed as our confident sample detection baseline, which has been proved successful in achieving high precision. In addition, a novel maximum-kernel-based metric function is introduced to rerank the images in the initial result. We evaluated the method on the standard Paris dataset and a new Francelandmark dataset. Our experiments demonstrate that the algorithm has great value on practicality because of its good performance, easy implementation, and high computational efficiency.

15 December 2018 in JMIR Preprints
Verified
Preprint
Open access
MGMengchun Gong
Mengchun Gong
SWShuang Wang
Shuang Wang
LWLezi Wang
Lezi Wang
CLChao Liu
Chao Liu
NBNan Bi
Nan Bi
ZHZhouguang Hui
Zhouguang Hui
BACKGROUND Patient privacy is a ubiquitous problem around the world. Many existing studies have demonstrated the potential privacy risks associated with sharing of biomedical data. Owing to the increasing need for data sharing and analysis, health care data privacy is drawing more attention. However, to better protect biomedical data privacy, it is essential to assess the privacy risk in the first place. OBJECTIVE In China, there is no clear regulation for health systems to deidentify data. It is also not known whether a mechanism such as the Health Insurance Portability and Accountability Act (HIPAA) safe harbor policy will achieve sufficient protection. This study aimed to conduct a pilot study using patient data from Chinese hospitals to understand and quantify the privacy risks of Chinese patients. METHODS We used g-distinct analysis to evaluate the reidentification risks with regard to the HIPAA safe harbor approach when applied to Chinese patients’ data. More specifically, we estimated the risks based on the HIPAA safe harbor and limited dataset policies by assuming an attacker has background knowledge of the patient from the public domain. RESULTS The experiments were conducted on 0.83 million patients (with data field of date of birth, gender, and surrogate ZIP codes generated based on home address) across 33 provincial-level administrative divisions in China. Under the Limited Dataset policy, 19.58% (163,262/833,235) of the population could be uniquely identifiable under the g-distinct metric (ie, 1-distinct). In contrast, the Safe Harbor policy is able to significantly reduce privacy risk, where only 0.072% (601/833,235) of individuals are uniquely identifiable, and the majority of the population is 3000 indistinguishable (ie the population is expected to share common attributes with 3000 or less people). CONCLUSIONS Through the experiments based on real-world patient data, this work illustrates that the results of g-distinct analysis about Chinese patient privacy risk are similar to those from a previous US study, in which data from different organizations/regions might be vulnerable to different reidentification risks under different policies. This work provides reference to Chinese health care entities for estimating patients’ privacy risk during data sharing, which laid the foundation of privacy risk study about Chinese patients’ data in the future.